Update on the genetics of age-related macular degeneration;Dégénérescence maculaire liée à l'âge et génétique: Données actuelles

Journal Francais d'Ophtalmologie

Volumn 31, Issue 6, 2008, Pages 630-637

  Fajnkuchen, F ^a,b   Cohen, S Y ^a,c  

^a Centre Ophtalmologique d'Imagerie et de Laser   (France)

^b AVICENNE HOSPITAL   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Age related macular degeneration; C2 FB; CFH; LOC 387715 HTRA1

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ARMS2 PROTEIN, HUMAN; COMPLEMENT C2, C ALLELE PROTEIN; COMPLEMENT COMPONENT C2; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H, HUMAN; HTRA1 PROTEIN, HUMAN; MEMBRANE PROTEIN; PLEKHA1 PROTEIN, HUMAN; PROTEIN; SERINE PROTEINASE; SIGNAL PEPTIDE;

AGED; CASE CONTROL STUDY; CHROMOSOME MAP; COMPLEMENT ALTERNATIVE PATHWAY; ENVIRONMENTAL EXPOSURE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC EPIGENESIS; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; MISSENSE MUTATION; ONSET AGE; PHYSIOLOGY; RETINA MACULA DEGENERATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; COMPLEMENT C2; COMPLEMENT FACTOR B; COMPLEMENT FACTOR H; COMPLEMENT PATHWAY, ALTERNATIVE; ENVIRONMENTAL EXPOSURE; EPIGENESIS, GENETIC; FEMALE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LINKAGE DISEQUILIBRIUM; MACULAR DEGENERATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; SERINE ENDOPEPTIDASES;

EID: 51049103400     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0181-5512(08)75469-X     Document Type: Article

References (54)

1. Scholl HP, Fleckenstein M, Charbel Issa P, Keilhauer C, Holz FG, Weber BH. An update on the genetics of age-related macular degeneration. Mol Vis 2007;13:196-205.
2. Souied E, Kaplan J, Coscas G, Soubrane G. DMLA et géné tique. J Fr Ophtalmol 2001;24:875-85.
3. Chamberlain M, Baird P, Dirani M, Guymer R. Unraveling a complex genetic disease: age-related macular degeneration. Surv Ophthalmol 2006;51:576-86.
4. Gorin MB. A clinician's view of the molecular genetics of age-related maculopathy. Arch Ophthalmol 2007;125:21-9.
5. Haddad S, Chen CA, Santangelo SL, Seddon JM. The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol 2006;51:316-63.
6. Souied E, Leveziel N, Kaplan J. Génétique. In: Soubrane G : « Les DMLAS ». Rapport de la Société Française d'Ophtalmologie. Paris, Masson Ed. 2007:67-80.
7. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C. Complement factor H polymorphism in age-related macular degeneration. Science 2005;308:385-9.
8. Edwards AO, Ritter R, 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005;308:421-4.
9. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005;308:419-21.
10. Shuler RK Jr, Hauser MA, Caldwell J, Gallins P, Schmidt S, Scott WK, et al. Neovascular age-related macular degeneration and its association with LOC387715 and complement factor H polymorphism. Arch Ophthalmol 2007 25: :63-7.
11. Thakkinstian A, Han P, McEvoy M, Smith W, Hoh J, Magnusson K, et al. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet 2006;15:2784-90.
12. Souied EH, Leveziel N, Richard F, Dragon-Durey MA, Coscas G, Soubrane G, et al. Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. Mol Vis 2005;11:1135-40.
13. Brantley MA Jr, Fang AM, King JM, Tewari A, Kymes SM, Shiels A. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab. Ophthalmology 2007;114:2168-73.
14. Schaumberg DA, Hankinson SE, Guo Q, Rimm E, Hunter DJ. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol 2007;125:55-62.
15. Grassi MA, Fingert JH, Scheetz TE, Roos BR, Ritch R, West SK, et al. Ethnic variation in AMD-associated complement factor H polymorphism p.Tyr402His. Hum Mutat 2006;27:921-5.
16. Tedeschi-Blok N, Buckley J, Varma R, Triche TJ, Hinton DR. Population-based study of early age-related macular degeneration: role of the complement factor H Y402H polymorphism in bilateral but not unilateral disease. Ophthalmology 2007;114:99-103.
17. Fuse N, Miyazawa A, Mengkegale M, Yoshida M, Wakusawa R, Abe T, et al. Polymorphisms in Complement Factor H and Hemicentin-1 genes in a Japanese population with dry-type age-related macular degeneration. Am J Ophthalmol 2006;142:1074-6.
18. Uka J, Tamura H, Kobayashi T, Yamane K, Kawakami H, Minamoto A, et al. No association of complement factor H gene polymorphism and age-related macular degeneration in the Japanese population. Retina 2006;26:985-7.
19. Lau LI, Chen SJ, Cheng CY, Yen MY, Lee FL, Lin MW, et al. Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients. Invest Ophthalmol Vis Sci 2006;47:3242-6.
20. Chen LJ, Liu DT, Tam PO, Chan WM, Liu K, Chong KK. Association of complement factor H polymorphisms with exudative age-related macular degeneration. Mol Vis 2006;12:1536-42.
21. Postel EA, Agarwal A, Caldwell J, Gallins P, Toth C, Schmidt S, et al. Complement factor H increases risk for atrophic age-related macular degeneration. Ophthalmology 2006;113:1504-7.
22. Grassi MA, Folk JC, Scheetz TE, Taylor CM, Sheffield VC, Stone EM. Complement factor H polymorphism p.Tyr402His and cuticular Drusen. Arch Ophthalmol 2007;125:93-7.
23. Brantley MA Jr, Edelstein SL, King JM, Apte RS, Kymes SM, Shiels A. Clinical phenotypes associated with the complement factor H Y402H variant in age-related macular degeneration. Am J Ophthalmol 2007;144:404-8.
24. Wegscheider BJ, Weger M, Renner W, Steinbrugger I, März W, Mossböck G, et al. Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration. Ophthalmology 2007;114:738-42.
25. Seitsonen S, Järvelä I, Meri S, Tommila P, Ranta P, Immonen I. Complement factor H Y402H polymorphism and characteristics of exudative age-related macular degeneration lesions. Acta Ophthalmol Scand 2007 [Epub ahead of print].
26. Rodriguez de Cordoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 2004;41:355-67.
27. Ennis S, Goverdhan S, Cree A, Hoh J, Collins A, Lotery A. Fine-scale linkage disequilibrium mapping of age-related macular degeneration in the complement factor H gene region. Br J Ophthalmol 2007;91:966-70.
28. Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 2006;38:1173-7.
29. Hageman GS, Hancox LS, Taiber AJ, Gehrs KM, Anderson DH, Johnson LV, et al. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med 2006;38:592-604.
30. Spencer KL, Hauser MA, Olson LM, Schmidt S, Scott WK, Gallins P, et al. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet 2007;16:1986-92.
31. Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H, et al.; Genetic Factors in AMD Study Group.Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 2007;357:553-61.
32. Dinu V, Miller PL, Zhao H. Evidence for association between multiple complement pathway genes and AMD. Genet Epidemiol 2007;31:224-37.
33. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006;38:458-62.
34. Spencer KL, Hauser MA, Olson LM, Schnetz-Boutaud N, Scott WK, Schmidt S, et al. Haplotypes spanning the complement factor H gene are protective against age-related macular degeneration. Invest Ophthalmol Vis Sci 2007;48:4277-83.
35. Seddon JM, Santangelo SL, Book K, Chong S, Cote J. A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet 2003;73:780-90.
36. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 2005;77:389-407.
37. Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger T, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005;14:3227-36.
38. Conley YP, Jakobsdottir J, Mah T, Weeks DE, Klein R, Kuller L, et al. CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. Hum Mol Genet 2006;15:3206-18.
39. Leveziel N, Souied EH, Richard F, Barbu V, Zourdani A, Morineau G, et al. PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population. Mol Vis 2007;13:2153-9.
40. Schmidt S, Hauser MA, Scott WK, Postel EA, Agarwal A, Gallins P, et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 2006;78:852-64.
41. Kanda A, Chen W, Othman M, Branham KE, Brooks M, Khanna R, et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci USA 2007;104:16227-32.
42. Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C, et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006;314:989-92.
43. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006;314:992-3.
44. Yoshida T, DeWan A, Zhang H, Sakamoto R, Okamoto H, Minami M, et al. HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration. Mol Vis 2007;13:545-8.
45. Cameron DJ, Yang Z, Gibbs D, Chen H, Kaminoh Y, Jorgensen A, et al. HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration. Cell Cycle. 2007;2;6:1122-5.
46. Weger M, Renner W, Steinbrugger I, Köfer K, Wedrich A, Groselj-Strele A, et al. Association of the HTRA1 -625G>A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population. Mol Vis. 2007; 24;13:1274-9.
47. Deangelis MM, Ji F, Adams S, Morrison MA, Harring AJ, Sweeney MO, et al. Alleles in the HtrA Serine Peptidase 1 gene alter the risk of neovascular age-related macular degeneration. Ophthalmology 2007 [Epub ahead of print].
48. DeWan A, Bracken MB, Hoh J. Two genetic pathways for age-related macular degeneration. Curr Opin Genet Dev 2007;17:228-33.
49. Maller J, George S, Purcell S, Fagerness J, Altshuler D, Daly MJ, et al. Common variation in three genes, including a non-coding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 2006;38:1055-9.
50. Despriet DD, Klaver CC, Witteman JC, Bergen AA, Kardys I, de Maat MP et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 2006;296:301-9.
51. Spencer KL, Hauser MA, Olson LM, Schnetz-Boutaud N, Scott WK, Schmidt S, et al. Haplotypes spanning the complement factor H gene are protective against age-related macular degeneration. Invest Ophthalmol Vis Sci 2007;48: 4277-83.
52. Hughes AE, Orr N, Patterson C, Esfandiary H, Hogg R, McConnell V, et al. Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. PLoS Med 2007;4:e355 (on line)
53. Seddon JM, George S, Rosner B, Klein ML. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered 2006;61:157-65.
54. McGeer PL, Sibley J. Sparing of age-related macular degeneration in rheumatoid arthritis. Neurobiol Aging 2005;26: 1199-203.